MERCORELLI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.092
AS - Asia 2.867
EU - Europa 1.433
SA - Sud America 457
AF - Africa 416
Continente sconosciuto - Info sul continente non disponibili 132
OC - Oceania 37
Totale 10.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.810
SG - Singapore 910
CN - Cina 619
IT - Italia 410
VN - Vietnam 337
BR - Brasile 296
HK - Hong Kong 287
DE - Germania 149
FI - Finlandia 101
BD - Bangladesh 89
FR - Francia 89
IN - India 89
RU - Federazione Russa 72
GB - Regno Unito 70
CA - Canada 64
SE - Svezia 62
PL - Polonia 61
NL - Olanda 58
AR - Argentina 46
UA - Ucraina 44
KR - Corea 42
ID - Indonesia 37
IQ - Iraq 35
JP - Giappone 35
TR - Turchia 34
ZA - Sudafrica 30
MX - Messico 28
SA - Arabia Saudita 28
PK - Pakistan 27
AT - Austria 25
CI - Costa d'Avorio 24
IE - Irlanda 23
IL - Israele 23
MY - Malesia 23
ES - Italia 22
CZ - Repubblica Ceca 20
EC - Ecuador 20
PH - Filippine 20
KE - Kenya 17
NI - Nicaragua 17
UZ - Uzbekistan 17
MA - Marocco 16
RE - Reunion 16
VE - Venezuela 16
CR - Costa Rica 15
ET - Etiopia 15
HR - Croazia 15
LB - Libano 15
PY - Paraguay 15
CW - ???statistics.table.value.countryCode.CW??? 14
GH - Ghana 14
NP - Nepal 14
SK - Slovacchia (Repubblica Slovacca) 14
TN - Tunisia 14
AZ - Azerbaigian 13
EG - Egitto 13
GT - Guatemala 13
JM - Giamaica 13
KG - Kirghizistan 13
LU - Lussemburgo 13
MU - Mauritius 13
NC - Nuova Caledonia 13
PA - Panama 13
TH - Thailandia 13
BS - Bahamas 12
CD - Congo 12
HT - Haiti 12
HU - Ungheria 12
JO - Giordania 12
RS - Serbia 12
SN - Senegal 12
UY - Uruguay 12
AO - Angola 11
BO - Bolivia 11
CL - Cile 11
DK - Danimarca 11
GF - Guiana Francese 11
GR - Grecia 11
IS - Islanda 11
LY - Libia 11
MR - Mauritania 11
MZ - Mozambico 11
AM - Armenia 10
BE - Belgio 10
BW - Botswana 10
BY - Bielorussia 10
BZ - Belize 10
CH - Svizzera 10
CO - Colombia 10
CU - Cuba 10
DJ - Gibuti 10
DO - Repubblica Dominicana 10
GA - Gabon 10
GE - Georgia 10
HN - Honduras 10
KZ - Kazakistan 10
MD - Moldavia 10
ML - Mali 10
PR - Porto Rico 10
TZ - Tanzania 10
Totale 9.919
Salva come PNG Salva come JPEG
Città #
Ashburn 662
Singapore 572
Fairfield 515
San Jose 459
Woodbridge 264
Hong Kong 251
Houston 236
Chandler 232
Cambridge 195
Seattle 194
Ann Arbor 190
Beijing 149
Wilmington 144
Santa Clara 143
Ho Chi Minh City 98
Los Angeles 94
Hanoi 72
Boardman 70
Helsinki 58
Council Bluffs 57
New York 54
San Diego 54
Jacksonville 50
Princeton 43
Hefei 42
Milan 41
Guangzhou 39
Lauterbourg 38
Munich 38
Bytom 35
Seoul 32
Roxbury 31
São Paulo 31
Rome 29
Medford 28
Padova 27
Orem 26
Dearborn 25
Frankfurt am Main 25
Abidjan 24
The Dalles 24
Columbus 22
Da Nang 22
Johannesburg 22
Shanghai 22
Tokyo 22
Buffalo 21
Dallas 21
Nanjing 21
Naples 21
Brooklyn 20
Des Moines 20
Chicago 19
Dublin 18
Baghdad 17
Managua 17
Perugia 17
Warsaw 16
Dong Ket 15
Haiphong 15
Montreal 15
Padua 15
Accra 14
Boston 14
Baku 13
Manchester 13
Nairobi 13
Noumea 13
Nuremberg 13
San José 13
Shenyang 13
Willemstad 13
Addis Ababa 12
Amman 12
Dakar 12
Denver 12
London 12
Nassau 12
Panama City 12
Pune 12
Stockholm 12
Chennai 11
Elk Grove Village 11
Jeddah 11
Kinshasa 11
Maputo 11
Nouakchott 11
Poplar 11
Tashkent 11
Vienna 11
Bishkek 10
Havana 10
Phoenix 10
Prague 10
Redondo Beach 10
Yerevan 10
Atlanta 9
Bamako 9
Dar es Salaam 9
Gaborone 9
Totale 6.224
Salva come PNG Salva come JPEG
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 368
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 300
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 299
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 285
Antiviral strategies against influenza virus: towards new therapeutic approaches. 280
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 277
The 6-Aminoquinolone WC5 Inhibits Human Cytomegalovirus Replication at an Early Stage by Interfering with the Transactivating Activity of Viral Immediate-Early 2 Protein 270
A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity 269
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication 262
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 261
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. 258
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 254
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 252
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 249
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 249
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. 245
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 239
Drug Repurposing for Viral Infectious Diseases: How Far Are We? 234
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" 229
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 228
The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 is Modified by SUMO in a DNA-dependent manner 228
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs 224
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives. 222
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 222
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 220
A point mutation in a herpesvirus polymerase determines neuropathogenicity. 219
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 214
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 213
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. 212
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication 212
Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein. 211
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism 209
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches 207
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein 206
Human cytomegalovirus DNA replication: antiviral targets and drugs. 205
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 201
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors 199
The 6-Aminoquinolone WC5 Inhibits Different Functions of the Immediate-Early 2 (IE2) Protein of Human Cytomegalovirus That Are Essential for Viral Replication. 192
Sulfated Derivatives of Escherichia coli K5 Polysaccharide are Potent Inhibitors of Human Cytomegalovirus. 184
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 175
Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses. 175
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability 168
Caratterizzazione di nuovi composti antivirali contro il citomegalovirus umano e studio del meccanismo di neuropatogenocità nel herpesvirus equino di tipo 1 157
Composition and methods for the treatment of pathological condition associated with cytomegalovirus infection. 107
Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer 100
Antiviral drug repurposing: different approaches and the case of antifungal drugs 81
New dengue virus inhibitors targeting NS3-NS5 interaction identified by in silico screening 59
PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens 47
Rationally optimized mucroporin-M1 peptides disrupt viral envelopes and resist degradation 20
Letermovir shows antiviral and neuroprotective effects in differentiating neurons and cerebral organoids mimicking human developing brain 20
Discovery of a tetrahydrobenzothiophen-2-yl-pyrazolo[1,5-a]pyrimidine-3-carboxamide-based PROTAC as degrader of SARS-CoV-2 main protease 17
Totale 10.434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.105
article - articoli 27.626
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 330
selected - selezionate 0
volume - volumi 644
Totale 57.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022579 0 70 90 51 47 29 34 64 13 18 59 104
2022/2023510 86 55 22 48 91 64 4 40 49 17 32 2
2023/2024388 7 51 62 26 40 33 45 27 8 32 25 32
2024/20251.388 5 156 72 47 153 52 97 102 86 70 205 343
2025/20265.247 290 395 634 787 470 262 760 446 469 297 249 188
2026/2027297 243 54 0 0 0 0 0 0 0 0 0 0
Totale 10.434